Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

1,453

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

1,453 results for “Outcome research”

Learn how ShareScore rates datasets ↗
zenodo36/100

Figure 1. from: Unicorn–Open science for assessing environmental state, human health and regional economy - Research Ideas and Outcomes 2: e9232 (16 May 2016) https://doi.org/10.3897/rio.2.e9232

Figure 1. - Links and interactions between the work packages

opencc-by-4.0Feb 2017View details →
zenodo36/100

Figure 4. from: Defining the Scholarly Commons - Reimagining Research Communication. Report of Force11 SCWG Workshop, Madrid, Spain, February 25-27, 2016 - Research Ideas and Outcomes 2: e9340 (26 May 2016) https://doi.org/10.3897/rio.2.e9340

Figure 4. - Perspective Engine

opencc-by-4.0Feb 2017View details →
zenodo36/100

Figure 2. from: Defining the Scholarly Commons - Reimagining Research Communication. Report of Force11 SCWG Workshop, Madrid, Spain, February 25-27, 2016 - Research Ideas and Outcomes 2: e9340 (26 May 2016) https://doi.org/10.3897/rio.2.e9340

Figure 2. - Opening night presentation by Maryann Martone (available as Google Slides)

opencc-by-4.0Feb 2017View details →
zenodo36/100

Advancing the Adverse Outcome Pathway (AOP) in Radiation Research: An International Horizon-Style Exercise

<p>Over the past few decades, the chemical and ecotoxicology fields have been using the Adverse Outcome Pathway (AOP) framework to advance research and regulation. This framework offers an effective means to organize biological data into key events in the progression to an adverse outcome of interest to regulatory decision-making. The AOP framework is gaining traction within the radiation risk assessment community as the framework provides a linkage between experimentally derived biological data at different levels of biological organization with disease progression. It is envisioned that the AOP framework can strengthen the weight of evidence, decrease the uncertainty in radiation risk assessment, and enhance the understanding of radiation-induced effects at low doses and low dose rates. However, to advance the AOP framework within the field of radiation, uptake from the research community, policy makers, regulators and other stakeholders (e.g., industry) will be required.</p> <p>To explore the diversity of opinions and ideas on incorporating the AOP framework in research and regulation, an international horizon-style exercise is being undertaken by the Nuclear Energy Agency&rsquo;s High-Level Group on Low Dose Research (HLG-LDR) Radiation/Chemical (Rad/Chem) AOP joint topical group.&nbsp; This exercise will identify the most important open questions regarding the use of the AOP framework in radiation research and regulation. The vision of the topical group is to demonstrate AOPs as an essential tool to characterize the knowledge domain, define evidence gaps, and ultimately, inform research directions based on knowledge from both the chemical and the radiation research communities. The first phase of the horizon-style exercise, the candidate question solicitation, is now complete with input from around the globe. Currently, a dedicated steering committee is sorting the collected questions with the intent to identifying key areas where radiation AOPs can support and identify challenges to its implementation in regulatory decision-making.&nbsp; Completion of this phase of the exercise will identify the most important questions for inclusion in an international survey. The survey will permit survey respondents to highlight priority questions specific to individual interests. The outcome of the international survey will guide future initiatives of the Rad/Chem AOP joint topical group, inform focused workshop topics, and ultimately facilitate the integration of the AOP framework into radiation risk assessment and radiation protection.</p>

opencc-by-2.0Nov 2021View details →
ClinicalTrials.gov36/100

Potato Research for Enhancing Metabolic Outcomes

ClinicalTrials.gov study NCT04203238. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer

ClinicalTrials.gov study NCT04049747. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

PREDICT-H Study: Prospective Research on Essential Determinants Influencing Complication Trends in Hypospadias - a Landmark Prospective Multicenter Cohort Study Aimed at Improving Outcome Prediction i

ClinicalTrials.gov study NCT07017842. IPD Sharing: YES. Countries: 1. Publications: 5.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION

ClinicalTrials.gov study NCT04333732. IPD Sharing: YES. Countries: 5. Publications: 4.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Rheumatoid Arthritis Satisfaction Outcome Research

ClinicalTrials.gov study NCT03703817. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Patient-centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research

ClinicalTrials.gov study NCT02146274. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension

ClinicalTrials.gov study NCT02867813. IPD Sharing: YES. Countries: 7. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

The Maximizing Extubation Outcomes Through Educational and Organizational Research (METEOR) Trial

ClinicalTrials.gov study NCT05523479. IPD Sharing: YES. Countries: 1. Publications: 7.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk

ClinicalTrials.gov study NCT01764633. IPD Sharing: Not stated. Countries: 49. Publications: 30.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Comparative Effectiveness Research to Enhance Outcomes in African-Americans With Obstructive Sleep Apnea

ClinicalTrials.gov study NCT01997723. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Lumbar Stenosis Outcomes Research (LUSTOR)

ClinicalTrials.gov study NCT00638443. IPD Sharing: Not stated. Countries: 1. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Lumbar Stenosis Outcomes Research II

ClinicalTrials.gov study NCT00652093. IPD Sharing: Not stated. Countries: 1. Publications: 6.

restrictedIPD-UNDECIDEDFeb 2026View details →
zenodo32/100

Supplementary material 3 from: Pericleous C, Eliades N-GH (2020) An approach for the mass propagation of Cupressus sempervirens L. (Cupressaceae), for quality propagule production. Research Ideas and Outcomes 6: e52947. https://doi.org/10.3897/rio.6.e52947

Full package of ANOVA based on the different treatments applied for propagation of C. sempervirens f. sempervirens.

opencc-zeroApr 2020View details →
zenodo32/100

Supplementary material 1 from: Pericleous C, Eliades N-GH (2020) An approach for the mass propagation of Cupressus sempervirens L. (Cupressaceae), for quality propagule production. Research Ideas and Outcomes 6: e52947. https://doi.org/10.3897/rio.6.e52947

Number of shoots per tested parameters on axillary shoots proliferation in C. sempervirens f. sempervirens.

opencc-zeroApr 2020View details →
zenodo32/100

Supplementary material 3 from: Petersen M, Pramann B, Toepfer R, Neumann J, Enke H, Hoffmann J, Mauer R (2020) Research Data Management - Current status and future challenges for German non-university research institutions. Research Ideas and Outcomes 6: e55141. https://doi.org/10.3897/rio.6.e55141

Praxisbericht: Entwicklung eines Maßnahmenkatalogs zur Verbesserung des Forschungsdatenmanagements am Herder-Institut für historische Ostmitteleuropaforschung

opencc-zeroJun 2020View details →
zenodo32/100

Supplementary material 11 from: Tomaskinova J, Dicks L, Collier M, Geneletti D, Grace M, Longato D, Sadula R, Stoev P, Sapundzhieva A, Balzan MV (2020) Capacity-building and networking events for nature-based solutions and re-naturing in Malta. Research Ideas and Outcomes 6: e60893. https://doi.org/10.3897/rio.6.e60893

Identifying priority knowledge needs for implementing nature-based solutions-results from Malta and other Mediterranean islands

opencc-zeroNov 2020View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record